A Clinical Study to Investigate and Compare the Impact of High Protein Pasta, Lower Protein Pasta and White Rice on Blood Sugar Control in People With Type 1 Diabetes Mellitus (T1DM)
1 other identifier
interventional
14
1 country
1
Brief Summary
The aim of this clinical study is to investigate and compare the postprandial glycemic response to three different meal types rich in carbohydrates, that is, white pasta, high protein pasta and white rice consumed by individuals with T1DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2017
CompletedFirst Posted
Study publicly available on registry
December 5, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 2, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 2, 2018
CompletedSeptember 5, 2018
September 1, 2018
7 months
November 29, 2017
September 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Delta glucose (maximum rise from baseline glucose) mg/dL
Delta glucose (maximum rise from baseline glucose) from the start of the meal to the peak continuous glucose monitoring (CGM) glucose reading (mg/dL) during the 5-hour postprandial window, compared between the three meal types.
5 hours
Secondary Outcomes (3)
Incremental area under the curve (area)
5 hours
Time to peak glucose level (minutes)
5 hours
percent time glucose <70 mg/dL
5 hours
Study Arms (3)
Regular pasta
EXPERIMENTALSubjects will bolus rapid acting insulin per their carbohydrate ratio just prior to a meal of regular pasta. They will consume this meal on two separate occasions.
High protein pasta
EXPERIMENTALSubjects will bolus rapid acting insulin per their carbohydrate ratio just prior to a meal of high protein pasta. They will consume this meal on two separate occasions.
White rice
EXPERIMENTALSubjects will bolus rapid acting insulin per their carbohydrate ratio just prior to a meal of white rice. They will consume this meal on two separate occasions.
Interventions
High protein pasta (Approximately 38 grams carbohydrate per meal)
Eligibility Criteria
You may qualify if:
- Age ≥ 18 and ≤ 75 years at the time of screening.
- Clinical diagnosis of type 1 diabetes for at least one year.
- HbA1c ≤ 10%, as performed by point of care or central laboratory testing. A1c will be assessed at the screening visit, or if already completed within 2 months of the screening visit, the prior lab value may be used in lieu of repeating this assessment.
- Currently using insulin-to-carbohydrate ratio to calculate meal bolus sizes, and boluses for all meals and snacks that contain ≥ 5 grams of carbohydrate.
- Willing to refrain from taking acetaminophen products for the duration of the clinical trial. If acetaminophen is taken, subject is to avoid making any insulin dosing decisions based on CGM for at least 12 hours.
- For females, not currently known to be pregnant. If female and sexually active, must agree to use a form of contraception to prevent pregnancy while a participant in the study. A negative urine pregnancy test will be required for all premenopausal women who are not surgically sterile at the screening visit. Subjects who become pregnant will be discontinued from the study.
- Willing to abide by the study protocol and use study-provided devices.
You may not qualify if:
- Gastrointestinal disease such as celiac disease or multiple food allergies.
- Any form of gluten sensitivity or wheat allergy.
- Allergies to any form of nuts and ingredients present in the study meals (tomatoes etc).
- History of gastroparesis.
- Pregnancy.
- Dermatological conditions that would preclude wearing a CGM sensor.
- Screening A1c \> 10%.
- Any condition that could interfere with participating in the trial, based on the investigator's judgment.
- A recent injury to body or limb, muscular disorder, use of any medication, any carcinogenic disease, or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the protocol.
- Participation in another pharmaceutical or device trial at the time of enrollment or during the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sansum Diabetes Research Institutelead
- Harvard Universitycollaborator
Study Sites (1)
Sansum Diabetes Research Institute
Santa Barbara, California, 93105, United States
Related Publications (1)
Zavitsanou S, Massa J, Deshpande S, Pinsker JE, Church MM, Andre C, Doyle Iii FJ, Michelson A, Creason J, Dassau E, Eisenberg DM. The Effect of Two Types of Pasta Versus White Rice on Postprandial Blood Glucose Levels in Adults with Type 1 Diabetes: A Randomized Crossover Trial. Diabetes Technol Ther. 2019 Sep;21(9):485-492. doi: 10.1089/dia.2019.0109. Epub 2019 Jun 21.
PMID: 31225739DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Eisenberg, MD
Harvard School of Public Health (HSPH)
- PRINCIPAL INVESTIGATOR
Eyal Dassau, PhD
Harvard University
- PRINCIPAL INVESTIGATOR
Jordan E Pinsker, MD
Sansum Diabetes Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Subjects will not be told which meal they are eating.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2017
First Posted
December 5, 2017
Study Start
January 1, 2018
Primary Completion
August 2, 2018
Study Completion
August 2, 2018
Last Updated
September 5, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share